Aculeus Therapeutics

Private

ParkvilleHealthcare & Life Scienceshttp://www.aculeustherapeutics.com/

Last Round

SAFE

Sep 1, 2023

Total Funding Raised

$1.46M

Company Overview

Aculeus Therapeutics is a biotechnology company that develops small molecule drugs that modulate the immune system for the treatment of cancer and other serious diseases.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine

Business Model

B2B

Customer Profile

Revenue Share

AI Layer

Non-AI

Keywords

immuno-oncologySTING agonistsmall molecule drugsdrug discoverySTING pathwaycancer therapyENPP1 inhibitorpreclinical biotechnologyinnate immunityAcute Myeloid LeukemiaAMLdrug in-licensingsemi-virtual biotech

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Aculeus Therapeutics Comparables

Compare Aculeus Therapeutics with similar companies based on industry and business-model similarity.

Aculeus Therapeutics comparables — related companies by embedding similarity
Company	Similarity	Market Cap

View Full Comparables Set

Access detailed peer comparisons, similarity scores, and market data.

Aculeus Therapeutics Funding Rounds

Historical fundraising activity

Data table
Round	Date	Amount Raised	Valuation	Investors	Sources
SAFE	Sep 1, 2023
Grant	Jul 23, 2021
Grant	Nov 9, 2020

View all Funding Rounds

Aculeus Therapeutics Investors

Notable investors and investment history

Aculeus Therapeutics investors
Investor	Rounds
Therapeutic Innovation Australia	Grant
SYNthesis BioVentures	SAFE

View all Investors

Market signals

Structured signals derived from secondary market and firmographic data.

Sep 1, 2023
$1.46M round led by SYNthesis BioVentures
Jul 23, 2021
Received grant funding from Therapeutic Innovation Australia.

View all signals

Aculeus Therapeutics Filings

SEC and related filings with document metadata.

Data table
Typed	Date	Amount Offered	Amount Sold	Filling	Pages	Download
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation

Aculeus Therapeutics Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Aculeus Therapeutics's valuation, stock price, and market status.

Firmographic Details

HeadquartersParkville

Year Founded2020

Last FundingSep 1, 2023

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.